ESC 365 - Diabetes and cardiovascular risk

Back

ESC Premium Access

Diabetes and cardiovascular risk – Ugly twins

Session: GLP-1 Receptor agonists – Pioneers of further cardiovascular risk reduction in diabetes?

Topic: Diabetes and the Heart

Speaker: Professor L. Leiter (Toronto, CA)

Sponsored by Medscape through an independent educational grant from Novo Nordisk

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Lawrence Leiter

University of Toronto, Toronto (Canada)

19 presentations

0 follower

5 more presentations in this session

Incretins and glucose homeostasis

Speaker: Doctor J. Meier (Bochum, DE)

Access

Slides

Video

GLP-1 and the cardiovascular system

Speaker: Doctor M. Husain (Toronto, CA)

Access

Slides

Video

Pioneering oral GLP-1 RAs in cardiovascular risk management

Speaker: Professor A. Consoli (Pescara, IT)

Access

Slides

Oral GLP-1 RA – a step change in cardiology?

Speaker: Professor L. Leiter (Toronto, CA)

Access

Slides

Video

Panel discussion

Speaker: Professor L. Leiter (Toronto, CA)

Access

Video

Access the full session

GLP-1 Receptor agonists – Pioneers of further cardiovascular risk reduction in diabetes?

Speakers: Professor L. Leiter, Doctor J. Meier, Doctor M. Husain, Professor A. Consoli, Professor L. Leiter...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources